Taylor Lee

Taylor Lee

Auto-generated profile, based on publicly available information

Taylor Lee

Department of Pathology and Laboratory Medicine, University of Wisconsin-Madison, Madison, WI, 53705, USA

Research Focus & Metrics

Academic Career Length

8Years (2019-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
18 July 2019 in Immunogenetics
Verified
Journal Article
Closed access
PDF file
JCJohn R. Caskey
John R. Caskey
RWRoger W. Wiseman
Roger W. Wiseman
JKJulie A. Karl
Julie A. Karl
DBDavid A. Baker
David A. Baker
TLTaylor Lee
Taylor Lee
DODavid O'Connor
David O'Connor

2 May 2019 in bioRxiv
Verified
Preprint
Open access
PDF file
JCJohn R. Caskey
John R. Caskey
RWRoger W. Wiseman
Roger W. Wiseman
JKJulie A. Karl
Julie A. Karl
DBDavid A. Baker
David A. Baker
TLTaylor Lee
Taylor Lee
DODavid O'Connor
David O'Connor
Indian rhesus macaque major histocompatibility complex (MHC) variation can influence the outcomes of transplantation and infectious disease studies. Frequently, rhesus macaques are MHC genotyped to identify variants that could account for unexpected results. Since the MHC is only one region in the genome where variation could impact experimental outcomes, strategies for simultaneously profiling variation in the macaque MHC and the remainder of the protein coding genome would be useful. Here we introduce m acaque e xome s equence (MES) genotyping, in which MHC class I and class II genotypes are determined with high confidence using target-enrichment probes that are enriched for MHC sequences. For a cohort of 27 Indian rhesus macaques, we describe two methods for obtaining MHC genotypes from MES data and demonstrate that the MHC class I and class II genotyping results obtained with these methods are 98.1% and 98.7% concordant, respectively, with expected MHC genotypes. In contrast, conventional MHC genotyping results obtained by deep sequencing of short multiplex PCR amplicons were only 92.6% concordant with expectations for this cohort.